Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Pioneer(R) Surgical Technology Acquires Angstrom(TM) Medica, Inc.

Abstract:
Pioneer Surgical Technology (PST) today announced its acquisition of Angstrom Medica, Inc., headquartered in Woburn, MA. Angstrom is the first company to obtain Food and Drug Administration (FDA) approval for a nanotechnology device -- NanOss(TM). NanOss chemistries enable products that are highly osteoconductive and can remodel over time into human bone. NanOss has potential application in trauma, spine and general orthopaedic markets. Terms of the acquisition were not disclosed. Angstrom Medica, Inc. becomes a wholly-owned subsidiary of PST and is part of its orthobiologics division.

Pioneer(R) Surgical Technology Acquires Angstrom(TM) Medica, Inc.

MARQUETTE, MI | Posted on October 24th, 2007

"Angstrom Medica and its innovative technology represent a strategic addition to the Pioneer family," said Matthew N. Songer, M.D., Chairman and CEO of PST. "This latest orthobiologic acquisition complements our mission by developing technology that empowers surgeons to restore patients to normal function with products and methods not currently available."

NanOss, like human bone, is made of hydroxyapatite crystals. By controlling the material at the nanocrystalline level the resulting compound can have the strength of established polymer surgical implants. According to Angstrom''s CEO Edward Ahn, Ph.D., "This biomaterial provides an opportunity for changing orthopaedic technology by offering surgeons and their patients devices that have great strength upon implantation and may gradually be replaced by living human bone."

Also in 2007, PST acquired Encelle, Inc., a North Carolina firm that develops novel products for tissue regeneration including E-Matrix(TM), a sterile, injectable biopolymer designed to repair or regenerate diseased or damaged tissue.

Said Wesley McDermott, PST''s Vice President for New Business Development, "The Angstrom acquisition further expands Pioneer''s position and opportunity in a growing orthobiologic market."

####

About Pioneer Surgical Technology (PST)
Pioneer Surgical Technology, headquartered in Marquette, Michigan, is a leading innovator in the design and manufacture of spinal and orthopedic implants. Founded in 1992, Pioneer is a true surgeon-driven spinal device company that promotes responsiveness through customer intimacy, and a commitment to innovation. Pioneer has launched several spinal implant systems: Quantum(TM) Spinal Rod, Pioneer? Anterior Cervical Plate, and PEEK-Plus Vertebral Body Replacement Devices. Pioneer also has received the European CE mark for the NUBAC(TM) Disc Arthroplasty System.

About Angstrom Medica, Inc.

Angstrom Medica, Inc. (http://www.angstrommedica.com) is a biomaterials and medical device company engaged in the development and commercialization of its proprietary nanocrystalline calcium phosphate technology -- NanOss(TM). The company was founded in 2001 by Dr. Ahn and two fellow Massachusetts Institute of Technology (MIT) researchers. In 2005, Angstrom was the recipient of Frost and Sullivan''s ''Excellence in Technology Award''. The company is currently located in Woburn, MA.

For more information, please click here

Contacts:
Pioneer Surgical Technology
375 River Park Circle
Marquette, MI 49855
906-226-9909
906-226-4443 Fax

Sales & Marketing

Copyright © PR Newswire Association LLC.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Nanomedicine

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery: NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery September 13th, 2024

Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024

Nanobody inhibits metastasis of breast tumor cells to lung in mice: “In the present study we describe the development of an inhibitory nanobody directed against an extracellular epitope present in the native V-ATPase c subunit.” August 16th, 2024

Announcements

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Turning up the signal November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

Alliances/Trade associations/Partnerships/Distributorships

Manchester graphene spin-out signs $1billion game-changing deal to help tackle global sustainability challenges: Landmark deal for the commercialisation of graphene April 14th, 2023

Chicago Quantum Exchange welcomes six new partners highlighting quantum technology solutions, from Chicago and beyond September 23rd, 2022

CEA & Partners Present ‘Powerful Step Towards Industrialization’ Of Linear Si Quantum Dot Arrays Using FDSOI Material at VLSI Symposium: Invited paper reports 3-step characterization chain and resulting methodologies and metrics that accelerate learning, provide data on device pe June 17th, 2022

University of Illinois Chicago joins Brookhaven Lab's Quantum Center June 10th, 2022

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project